BIG congrats to Kite Pharma!

August 28, 2017

The Los Angeles Times writes about Gilead’s acquisition of Kite Pharma.

“Santa Monica biotech company Kite Pharma Inc. is being acquired by industry giant Gilead Sciences Inc. in an $11.9-billion deal that demonstrates the promise of using a person’s own immune system to fight cancer.”